Publications
Below is a list of research publications published in scientific journals by WWARN and our research partners. Use the filters to explore the publications by research theme or by using our list of key words. All links lead to PubMed.
If you cannot find a publication, please email info@wwarn.org.
Mind the gaps--the epidemiology of poor-quality anti-malarials in the malarious world--analysis of the WorldWide Antimalarial Resistance Network database.
Tabernero, P., Fernández, F., Green, M., Guerin, P., & Newton, P. (2014). Malaria Journal, 13, 139.
Preventing the global spread of artemesinin resistance: Can we subvert evolution?
Guerin, P. (2014). International Journal of Infectious Diseases, 21, 16.
Defining the geographical range of the Plasmodium knowlesi reservoir.
Moyes, C., Henry, A., Golding, N., Huang, Z., Singh, B., Baird, J., Newton, P., Huffman, M., Duda, K., Drakeley, C., Elyazar, I., Anstey, N., Chen, Q., Zommers, Z., Bhatt, S., Gething, P., & Hay, S. (2014). PLoS Neglected Tropical Diseases, 8(3), e2780.
Pharmacovigilance for single low-dose primaquine: a practical approach
Poirot, E., Stergachis, A., ter Kuile, F., Guerin, P., Chen, I., & Gosling, R. (2014). Malaria Journal, 13(Suppl 1), P72 - P72.
The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data
Achan, J., Adam, I., Arinaitwe, E., Ashley, E., Awab, G., Barnes, K., Bassat, Q., Borrmann, S., Bousema, T., Dahal, P., D’Alessandro, U., Davis, T., Dondorp, A., Dorsey, G., Drakeley, C., Fanello, C., Faye, B., Flegg, J., Gaye, O., … Phyo, A. (2013). PLOS MEDICINE, 10(12), 1-17.
Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives
Flegg, J., Guérin, P., Nosten, F., Ashley, E., Phyo, A., Dondorp, A., Fairhurst, R., Socheat, D., Borrmann, S., Björkman, A., Mårtensson, A., Mayxay, M., Newton, P., Bethell, D., Se, Y., Noedl, H., Diakite, M., Djimde, A., Hien, T., … Stepniewska, K. (2013). Malaria Journal, 12.
Trends in antimalarial drug use in Africa.
Flegg, J., Metcalf, C., Gharbi, M., Venkatesan, M., Shewchuk, T., Hopkins Sibley, C., & Guerin, P. (2013). Am J Trop Med Hyg, 89(5), 857-865.
Surveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countries
Gharbi, M., Flegg, J., Pradines, B., Berenger, A., Ndiaye, M., Djimdé, A., Roper, C., Hubert, V., Kendjo, E., Venkatesan, M., Brasseur, P., Gaye, O., Offianan, A., Penali, L., Le Bras, J., & Guérin, P. (2013). PLoS ONE, 8(10), ARTN e77775.
Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
Tarning, J., Kloprogge, F., Dhorda, M., Jullien, V., Nosten, F., White, N., Guerin, P., & Piola, P. (2013). Antimicrob Agents Chemother, 57(10), 5096-5103.
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.
Woodrow, C., Dahlström, S., Cooksey, R., Flegg, J., Le Nagard, H., Mentré, F., Murillo, C., Ménard, D., Nosten, F., Sriprawat, K., Musset, L., Quashie, N., Lim, P., Fairhurst, R., Nsobya, S., Sinou, V., Noedl, H., Pradines, B., Johnson, J., … Le Bras, J. (2013). Antimicrobial Agents and Chemotherapy, 57(7), 3121-3130.
Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial.
Schramm, B., Valeh, P., Baudin, E., Mazinda, C., Smith, R., Pinoges, L., Dhorda, M., Boum, Y., Sundaygar, T., Zolia, Y., Jones, J., Comte, E., Houzé, P., Jullien, V., Carn, G., Ashley, E., & Guérin, P. (2013). Malar J, 12(1).
Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia.
Schramm, B., Valeh, P., Baudin, E., Mazinda, C., Smith, R., Pinoges, L., Sundaygar, T., Zolia, Y., Jones, J., Comte, E., Bruneel, A., Branger, M., Jullien, V., Carn, G., Kiechel, Ashley, E., & Guérin, P. (2013). Malar J, 12(1).
Early parasitological response following artemisinin-containing regimens: a critical review of the literature.
Das, D., Price, R., Bethell, D., Guerin, P., & Stepniewska, K. (2013). Malar J, 12(1).
Made in Europe: will artemisinin resistance emerge in French Guiana?
Nacher, M., Guérin, P., Demar-Pierre, M., Djossou, F., Nosten, F., & Carme, B. (2013). Malar J, 12(1).
Prognostic indicators in adults hospitalized with falciparum malaria in Western Thailand.
Newton, P., Stepniewska, K., Dondorp, A., Silamut, K., Chierakul, W., Krishna, S., Davis, T., Suputtamongkol, Y., Angus, B., Pukrittayakamee, S., Ruangveerayuth, R., Hanson, J., Day, N., & White, N. (2013). Malar J, 12(1).
How to achieve international action on falsified and substandard medicines.
Attaran, A., Barry, D., Basheer, S., Bate, R., Benton, D., Chauvin, J., Garrett, L., Kickbusch, I., Kohler, J., Midha, K., Newton, P., Nishtar, S., Orhii, P., & McKee, M. (2012). BMJ (Clinical Research Ed.), 345, e7381.
Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems.
Talisuna, A., Karema, C., Ogutu, B., Juma, E., Logedi, J., Nyandigisi, A., Mulenga, M., Mbacham, W., Roper, C., Guerin, P., D’Alessandro, U., & Snow, R. (2012). Lancet Infect Dis, 12(11), 888-896.
The WWARN antimalarial quality surveyor.
Tabernero, P., & Newton, P. (2012). Pathogens and Global Health, 106(2), 77-78.
A major genome region underlying artemisinin resistance in malaria.
Cheeseman, I., Miller, B., Nair, S., Nkhoma, S., Tan, A., Tan, J., Al Saai, S., Phyo, A., Moo, C., Lwin, K., McGready, R., Ashley, E., Imwong, M., Stepniewska, K., Yi, P., Dondorp, A., Mayxay, M., Newton, P., White, N., … Anderson, T. (2012). Science, 336(6077), 79-82.
No evidence for spread of Plasmodium falciparum artemisinin resistance to Savannakhet Province, Southern Laos.
Mayxay, M., Khanthavong, M., Chanthongthip, O., Imwong, M., Lee, S., Stepniewska, K., Soonthornsata, B., Pongvongsa, T., Phompida, S., Hongvanthong, B., Ringwald, P., White, N., & Newton, P. (2012). Am J Trop Med Hyg, 86(3), 403-408.
Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
Tarning, J., Kloprogge, F., Piola, P., Dhorda, M., Muwanga, S., Turyakira, E., Nuengchamnong, N., Nosten, F., Day, N., White, N., Guerin, P., & Lindegardh, N. (2012). Malar J, 11(1).
Childhood imported malaria: could we have suppressed risk factors in some children?
Pillai, S., Siriez, J.-Y., Kendjo, E., Houze, S., Guerin, P., & Le Bras, J. (2012). Malaria Journal, 11(Suppl 1), P53 - P53.
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodiun falciparum isolates from travelers returning from West Africa
Gharbi, M., Flegg, J., Hubert, V., Kendjo, E., Metcalf, J., Guerin, P., & Le Bras, J. (2012). Malaria Journal, 11(Suppl 1), P38 - P38.
Optimal sampling designs for accurate estimation of parasite clearance in the context of artemisinin resistance
Flegg, J., Guerin, P., Nosten, F., Dondorp, A., Fairhurst, R., Socheat, D., Borrmann, S., Björkman, A., Mårtensson, A., Mayxay, M., Newton, P., Bethell, D., Se, Y., Noedl, H., Djimde, A., White, N., & Stepniewska, K. (2012). Malaria Journal, 11(Suppl 1), P39 - P39.
The power of pooled analysis to inform optimal dosing strategies for Artemisinin Combination Therapies (ACTs)
Guerin, P., Moreira, C., Dahal, P., Piola, P., Stepniewska, K., & Price, R. (2012). Malaria Journal, 11(Suppl 1), P40 - P40.